Veeva Vault® is widely recognized in global pharmaceutical corporate offices for clinical and regulatory affairs. However, for plant-level manufacturing, quality control laboratories, and multi-facility operations in India, Southeast Asia, and the Middle East, manufacturing leaders often face critical operational constraints.
Data Sovereignty & Residency: Veeva operates exclusively as a multi-tenant public cloud. Novaqis offers complete deployment flexibility, allowing pharmaceutical enterprises to deploy on-premises within air-gapped plant networks, on dedicated private cloud instances, or in hybrid multi-plant topologies with full cryptographic offline licensing.
Shop-Floor Breadth: While Veeva focuses primarily on document and quality management, Novaqis natively incorporates a full 22-module Paperless LIMS and Electronic Batch Manufacturing Records (BRM) on the exact same database and identity stack—closing the loop between laboratory testing, floor execution, and quality release.
Workforce Enablement: Traditional per-user subscription tiers often force plants to restrict system access to office staff. Novaqis provides enterprise site licensing, enabling every operator, analyst, technician, and contractor to access governed SOPs and log training records under complete 21 CFR Part 11 audit trails.